ALPS
Price
$0.40
Change
+$0.01 (+2.56%)
Updated
Oct 2 closing price
Capitalization
66.56M
Intraday BUY SELL Signals
TCRX
Price
$0.32
Change
-$0.00 (-0.00%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
23.04M
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALPS vs TCRX

ALPS vs TCRX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALPS vs. TCRX commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPS is a StrongBuy and TCRX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
ALPSTCRX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
22%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
26%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (ALPS: $0.39 vs. TCRX: $0.32)
Brand notoriety: ALPS and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALPS: 12% vs. TCRX: 69%
Market capitalization -- ALPS: $66.56M vs. TCRX: $23.04M
ALPS [@Biotechnology] is valued at $66.56M. TCRX’s [@Biotechnology] market capitalization is $23.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPS’s FA Score shows that 1 FA rating(s) are green while TCRX’s FA Score has 1 green FA rating(s).

  • ALPS’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, ALPS is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPS’s TA Score shows that 3 TA indicator(s) are bullish while TCRX’s TA Score has 5 bullish TA indicator(s).

  • ALPS’s TA Score: 3 bullish, 4 bearish.
  • TCRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than ALPS.

Price Growth

ALPS (@Biotechnology) experienced а -2.50% price change this week, while TCRX (@Biotechnology) price change was -9.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

TCRX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ALPS
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BKMI24.930.09
+0.38%
BNY Mellon Municipal Intermediate ETF (BKMI)
OND32.78N/A
N/A
ProShares On-Demand ETF (OND)
ITDI42.37-0.07
-0.16%
iShares LifePath Target Date 2065 ETF (ITDI)
HAWX45.32-0.08
-0.18%
iShares Currency Hedged MSCI ACWI ex U.S. ETF (HAWX)
HYSD19.50-0.07
-0.36%
Columbia Short Duration High Yield ETF (HYSD)

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with CELC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+0.95%
CELC - TCRX
36%
Loosely correlated
-5.52%
MGX - TCRX
34%
Loosely correlated
+4.25%
AGIO - TCRX
33%
Poorly correlated
-2.32%
QURE - TCRX
33%
Poorly correlated
-3.27%
MLTX - TCRX
32%
Poorly correlated
-1.97%
More